Chief Administrative Officer/Secretary of the Board at iDream Inc., Marketing & Editorial Intern at The University of North Carolina Press
Location:
Atlanta, Georgia
Industry:
Nonprofit Organization Management
Work:
iDream Inc. - International since Jan 2013
Chief Administrative Officer/Secretary of the Board
The University of North Carolina Press - Chapel Hill, North Carolina since May 2013
Marketing & Editorial Intern
U.S. Department of Education - Washington D.C. Metro Area Dec 2012 - Jan 2013
Intern, Office of Postsecondary Education
Emory University - Greater Atlanta Area Aug 2011 - Dec 2012
Institutional Research Assistant | Research Assistant
North Carolina New Schools Project - Raleigh-Durham, North Carolina Area May 2012 - Aug 2012
Outreach, Policy, and Research Intern
Education:
Emory University 2011 - 2015
Certifications:
Notary Public Commission, State of North Carolina: Department of the Secretary of State Institutional Review Board Certification: Social and Behavioral Research, Cooperative Institutional Training Initiative
General Motors Dosp Specialist
Estero Bay Chevrolet Apr 2017 - Apr 2019
New Car Director
Germain Toyota Naples Jul 2016 - Apr 2017
Finance Director
Elco Chevrolet Cadillac Oct 2011 - Oct 2015
Finance Manager
Dean Team Automotive Group Jul 2008 - Aug 2011
Business Manager
Education:
Pensacola State College 2000 - 2002
Saint Charles High School 1988 - 1992
Skills:
Loan Origination Sales Management Sales Sales Process Loans Automotive Credit Profit Customer Retention Automobile Team Building Vehicles Finance Automotive Aftermarket Forecasting Negotiation Customer Satisfaction Dealer Management Warranty
Dr. Crowe graduated from the Medical University of South Carolina College of Medicine in 2004. He works in Houma, LA and specializes in Infectious Disease. Dr. Crowe is affiliated with Leonard J Chabert Medical Center.
Riverview AnesthesiologistRiverview Anesthesiologists PC 395 Westfield Rd, Noblesville, IN 46060 3177767280 (phone), 3177767920 (fax)
Education:
Medical School Indiana University School of Medicine Graduated: 1979
Languages:
English
Description:
Dr. Crowe graduated from the Indiana University School of Medicine in 1979. He works in Noblesville, IN and specializes in Anesthesiology. Dr. Crowe is affiliated with Riverview Health Hospital.
Medical School Wake Forest University School of Medicine Graduated: 1966
Languages:
English
Description:
Dr. Crowe graduated from the Wake Forest University School of Medicine in 1966. He works in Houston, TX and specializes in Pediatric Radiology. Dr. Crowe is affiliated with Baylor St Lukes Medical Center and Texas Childrens Hospital.
Googleplus
James Crowe
Lived:
New York, New York Toronto, Ontario
Education:
Rotman School of Management - Commerce & Finance / Economics
James Crowe
Work:
Danson Stables - Waiter (2011)
Education:
Beths Grammer School - Biology
James Crowe
Education:
University of Notre Dame - Finance, Needham High School
A key part of the plan is the $2.5 billion Ahead 100 project, which was pioneered by Vanderbilt Universitys Dr. James Crowe and calls for stockpiling antibodies to help respond to future pandemics.
Date: May 05, 2021
Category: More news
Source: Google
Researchers Develop 'Antibody Cocktail' That Can Block All Coronavirus Variants | The Weather Channel - Articles from The Weather Channel | weather.com
"This study highlights the importance of rationally designed antibody cocktails like those we developed," said James Crowe, Director of the Vanderbilt Vaccine Center (VVC). "We chose two antibodies to create a mixture that specifically would resist escape by SARS-CoV-2.
Date: Mar 06, 2021
Category: More news
Source: Google
Drug inspired by an old treatment could be ready by summer to treat COVID-19
One of the things about the search is its a little bit like finding a needle in a haystack. Were all searching for the magical antibody thats a silver bullet, said Dr. James Crowe, whos leading the Covid-19 monoclonal antibody effort at Vanderbilt University Medical Center.
Date: May 07, 2020
Category: More news
Source: Google
The race is on for antibodies that stop the new coronavirus
On 7 March, Dr. X visited the Vanderbilt lab led by James Crowe to donate blood. I couldnt really help my dad, the woman says. It was too late. So I want to make sure that fewer people have to go through what my family has gone through.
A public-private partnership called the Human Vaccines Project (HVP)hopes to bring this type of wide-ranging expertise to the table through its newly created Universal Influenza Vaccine Initiative (UIVI), led by Dr. James Crowe and Dr. Clarence B. Creech with the Vanderbilt University Medical Cente
Date: Mar 14, 2018
Category: Health
Source: Google
Scientists are now rushing to develop a universal flu vaccine
"The goal is to understand immunity to the flu and then convert that into a universal flu vaccine," said Dr. James Crowe, a pediatric infectious diseases physician at Vanderbilt University Medical Center in Nashville, Tennessee, and the director of UIVI. Similar to Palese's approach, UIVI is target
Date: Jan 26, 2018
Category: Top Stories
Source: Google
Get ready, some medical experts are predicting the worst flu season in history
the Universal Influenza Vaccine Initiative (UIVI). "The goal is to understand immunity to the flu and then convert that into a universal flu vaccine," said Dr. James Crowe, a pediatric infectious diseases physician at Vanderbilt University Medical Center in Nashville, Ten., and the director of UIVI.
Date: Jan 09, 2018
Category: Health
Source: Google
Antibodies May Provide 'Silver Bullet' for Ebola Viruses
James Crowe, MD, director of the Vanderbilt Vaccine Center, watches graduate student Andrew Flyak plate antibody-producing B cells from people in Africa who have survived infection by the Ebola virus. Courtesy of Vanderbilt University Medical CenterThere may be a "silver bullet" for Ebola, a "We thought we would need five different sets of vaccines or five different (drugs)," says James Crowe Jr., MD, the Ann Scott Carrell Professor and director of the Vanderbilt Vaccine Center, who led Vanderbilt's end of the research.